FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3128590573> ?p ?o ?g. }

• W3128590573 endingPage "4299" @default.
• W3128590573 startingPage "4289" @default.
• W3128590573 abstract "Temozolomide (TMZ), as the first-line chemotherapeutic agent for the treatment of glioblastoma multiforme (GBM), often fails to improve the prognosis of GBM patients due to the quick development of resistance. The need for more effective management of GBM is urgent. The aim of this study is to evaluate the efficacy of combined therapy with TMZ and amlexanox, a selective inhibitor of IKBKE, for GBM. We found that the combined treatment resulted in significant induction of cellular apoptosis and the inhibition of cell viability, migration, and invasion in primary glioma cells and in the human glioma cell line, U87 MG. As expected, TMZ enhanced the expression of p-AMPK and amlexanox led to the reduction of IKBKE, with no impact on p-AMPK. Furthermore, we demonstrated that compared to other groups treated with each component alone, TMZ combined with amlexanox effectively reversed the TMZ-induced activation of Akt and inhibited the phosphorylation of mTOR. In addition, the combination treatment also clearly reduced in vivo tumor volume and prolonged median survival time in the xenograft mouse model. These results suggest that amlexanox sensitized the primary glioma cells and U87 MG cells to TMZ at least partially through the suppression of IKBKE activation and the attenuation of TMZ-induced Akt activation. Overall, combined treatment with TMZ and amlexanox may provide a promising possibility for improving the prognosis of glioblastoma patients in clinical practice." @default.
• W3128590573 created "2021-02-15" @default.
• W3128590573 creator A5000385663 @default.
• W3128590573 creator A5007200458 @default.
• W3128590573 creator A5014697329 @default.
• W3128590573 creator A5016473420 @default.
• W3128590573 creator A5023838819 @default.
• W3128590573 creator A5024624317 @default.
• W3128590573 creator A5029869157 @default.
• W3128590573 creator A5041752671 @default.
• W3128590573 creator A5049199362 @default.
• W3128590573 creator A5082189423 @default.
• W3128590573 creator A5083617985 @default.
• W3128590573 creator A5084587848 @default.
• W3128590573 creator A5084918710 @default.
• W3128590573 date "2021-02-05" @default.
• W3128590573 modified "2023-10-13" @default.
• W3128590573 title "Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway" @default.
• W3128590573 cites W1677659983 @default.
• W3128590573 cites W1823890220 @default.
• W3128590573 cites W1970045743 @default.
• W3128590573 cites W1975722785 @default.
• W3128590573 cites W1980218169 @default.
• W3128590573 cites W1982652661 @default.
• W3128590573 cites W1984621921 @default.
• W3128590573 cites W1997071064 @default.
• W3128590573 cites W2001824102 @default.
• W3128590573 cites W2031683541 @default.
• W3128590573 cites W2062826804 @default.
• W3128590573 cites W2104153516 @default.
• W3128590573 cites W2107584818 @default.
• W3128590573 cites W2117609391 @default.
• W3128590573 cites W2128153359 @default.
• W3128590573 cites W2147696493 @default.
• W3128590573 cites W2164765107 @default.
• W3128590573 cites W2410408354 @default.
• W3128590573 cites W2412103425 @default.
• W3128590573 cites W2513360536 @default.
• W3128590573 cites W2526509295 @default.
• W3128590573 cites W2589936295 @default.
• W3128590573 cites W2725509061 @default.
• W3128590573 cites W2730708157 @default.
• W3128590573 cites W2747119573 @default.
• W3128590573 cites W2751629076 @default.
• W3128590573 cites W2754782102 @default.
• W3128590573 cites W2782730827 @default.
• W3128590573 cites W2791810919 @default.
• W3128590573 cites W2884888259 @default.
• W3128590573 cites W2887063367 @default.
• W3128590573 cites W2887102096 @default.
• W3128590573 cites W2896901762 @default.
• W3128590573 cites W3089828225 @default.
• W3128590573 cites W3105329007 @default.
• W3128590573 doi "https://doi.org/10.1021/acsomega.0c05399" @default.
• W3128590573 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7906592" @default.
• W3128590573 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33644550" @default.
• W3128590573 hasPublicationYear "2021" @default.
• W3128590573 type Work @default.
• W3128590573 sameAs 3128590573 @default.
• W3128590573 citedByCount "6" @default.
• W3128590573 countsByYear W31285905732021 @default.
• W3128590573 countsByYear W31285905732022 @default.
• W3128590573 countsByYear W31285905732023 @default.
• W3128590573 crossrefType "journal-article" @default.
• W3128590573 hasAuthorship W3128590573A5000385663 @default.
• W3128590573 hasAuthorship W3128590573A5007200458 @default.
• W3128590573 hasAuthorship W3128590573A5014697329 @default.
• W3128590573 hasAuthorship W3128590573A5016473420 @default.
• W3128590573 hasAuthorship W3128590573A5023838819 @default.
• W3128590573 hasAuthorship W3128590573A5024624317 @default.
• W3128590573 hasAuthorship W3128590573A5029869157 @default.
• W3128590573 hasAuthorship W3128590573A5041752671 @default.
• W3128590573 hasAuthorship W3128590573A5049199362 @default.
• W3128590573 hasAuthorship W3128590573A5082189423 @default.
• W3128590573 hasAuthorship W3128590573A5083617985 @default.
• W3128590573 hasAuthorship W3128590573A5084587848 @default.
• W3128590573 hasAuthorship W3128590573A5084918710 @default.
• W3128590573 hasBestOaLocation W31285905733 @default.
• W3128590573 hasConcept C2776194525 @default.
• W3128590573 hasConcept C2777389519 @default.
• W3128590573 hasConcept C502942594 @default.
• W3128590573 hasConcept C62478195 @default.
• W3128590573 hasConcept C71924100 @default.
• W3128590573 hasConcept C75217442 @default.
• W3128590573 hasConcept C86554907 @default.
• W3128590573 hasConcept C86803240 @default.
• W3128590573 hasConcept C95444343 @default.
• W3128590573 hasConcept C98274493 @default.
• W3128590573 hasConceptScore W3128590573C2776194525 @default.
• W3128590573 hasConceptScore W3128590573C2777389519 @default.
• W3128590573 hasConceptScore W3128590573C502942594 @default.
• W3128590573 hasConceptScore W3128590573C62478195 @default.
• W3128590573 hasConceptScore W3128590573C71924100 @default.
• W3128590573 hasConceptScore W3128590573C75217442 @default.
• W3128590573 hasConceptScore W3128590573C86554907 @default.
• W3128590573 hasConceptScore W3128590573C86803240 @default.
• W3128590573 hasConceptScore W3128590573C95444343 @default.
• W3128590573 hasConceptScore W3128590573C98274493 @default.

• next